UTAH MEDICAL PRODUCTS, INC. Operating Lease, Liability, Noncurrent
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Operating Lease, Liability, Noncurrent of $226.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-03-27
- 2025-12-31: Operating Lease, Liability, Noncurrent $226.00K.
- 2024-12-31: Operating Lease, Liability, Noncurrent $282.00K.
- 2024-09-30: Operating Lease, Liability, Noncurrent $299.00K.
- 2024-06-30: Operating Lease, Liability, Noncurrent $275.00K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2025-12-31 | $226.00K 10-K · filed 2026-03-27 |
| 2024-12-31 | $282.00K 10-K · filed 2025-03-26 |
| 2024-09-30 | $299.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $275.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $285.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $295.00K 10-Q · filed 2024-11-12 |
| 2023-09-30 | $305.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $315.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $328.00K 10-Q · filed 2023-05-05 |
| 2022-12-31 | $341.00K 10-K · filed 2024-03-26 |
| 2022-09-30 | $354.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $368.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $382.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $396.00K 10-K/A · filed 2023-03-28 |
| 2021-09-30 | $343.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $322.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $329.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $335.00K 10-K · filed 2022-03-25 |
| 2020-09-30 | $346.00K 10-Q/A · filed 2020-11-09 |
| 2020-06-30 | $356.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $366.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $376.00K 10-K · filed 2021-03-26 |
| 2019-09-30 | $385.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $395.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $405.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |